Neuroone Medical Technologies (NMTC) FCF Margin (2010 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly FCF Margin came in at 73.43% in Q1 2026, down 6915.0% YoY from 1.08% in Q1 2025, and up 32.71% on a QoQ basis from 109.13% in Q4 2025.
Neuroone Medical Technologies (NMTC) FCF Margin (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 13 years of FCF Margin data on file, last reported at 73.43% in Q1 2026.
- Quarterly FCF Margin fell 6915.0% year-over-year to 73.43% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 82.33% (up 371.0% YoY) and the FY2025 annual result came in at 32.09%, up 29030.0% from the prior year.
- FCF Margin improved to 73.43% in Q1 2026, from 109.13% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1383.43% in Q3 2022 to a low of 9061.09% in Q1 2022.
- A 5-year average of 1351.74% and a median of 287.63% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin tumbled 261163 bps — and 2023, when it jumped 826156 bps.
- Tracing NMTC's FCF Margin over 5 years: stood at 3057.95% in 2022, then jumped by 87 bps to 393.45% in 2023, then jumped by 101 bps to 5.61% in 2024, then sank by 2046 bps to 109.13% in 2025, then surged by 33 bps to 73.43% in 2026.
- The last three FCF Margin figures came in at 73.43% (Q1 2026), 109.13% (Q4 2025), and 56.05% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 18.73% |
| 10 | Neuroone Medical Technologies | 19.38 Mn | 17.33 Mn | 1.18 Mn | -55.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -55.82% |
| Mar 31, 2026 | -73.43% |
| Dec 31, 2025 | -109.13% |
| Sep 30, 2025 | -56.05% |
| Jun 30, 2025 | -88.86% |
| Mar 31, 2025 | -4.28% |
| Dec 31, 2024 | 5.61% |
| Sep 30, 2024 | -993.00% |
| Jun 30, 2024 | -287.63% |
| Mar 31, 2024 | -160.21% |
| Dec 31, 2023 | -393.45% |
| Sep 30, 2023 | -399.10% |
| Jun 30, 2023 | -488.89% |
| Mar 31, 2023 | -799.53% |
| Dec 31, 2022 | -3,057.95% |
| Sep 30, 2022 | 1,383.43% |
| Jun 30, 2022 | -8,396.07% |
| Mar 31, 2022 | -9,061.09% |
| Dec 31, 2021 | -8,120.86% |
| Sep 30, 2021 | -4,270.97% |